Immuno-oncology
JPM 2020 l The changing landscape of global healthcare in the new decade
I was struck by a resounding shift in attitude at this year’s J.P. Morgan Healthcare Conference; less talk, more action. The atmosphere felt more...
JPM 2019 |The fundamentals remain strong despite the doubters
I’ve taken longer than usual to write my JPM blog this year. It was a week when there was such a division of opinion...
Lateral thinking for oncology leadership
The rapid growth in immuno-oncology therapeutics is causing talent headaches for the pharma industry Patients are already benefitting from pharma’s success in developing new...